Daniela Stadler PhD Coriolis Pharma Research GmbH

Dr. Daniela Stadler is working as scientist at Coriolis Pharma, a science-driven contract research organization located in Munich, Germany, for formulation development, lyophilization, and analytics of biopharmaceuticals. She did her master’s degree in molecular biotechnology at the Technical University of Munich (TUM) in 2013. During her PhD (2013-2017) at the Institute of Virology at TUM she investigated hepatitis B virus DNA modification and degradation mechanisms induced by cytokines. As postdoctoral researcher at Helmholtz Zentrum München and TUM, her following studies focused on antiviral host proteins and drug repurposing against SARS-CoV-2. At Coriolis Pharma, she is working on the evaluation of particle analysis and characterization technologies with a focus on biopharmaceuticals.